Losing Weight With GLP-1s Shouldn’t Come With a Side of Shame

Introduction

“Damned if you do, damned if you don’t.”

That is how some people at a higher weight feel when they think about GLP-1 medications for weight loss.

They may feel judged for living in a bigger body. Then, if they decide to lose weight, they may feel judged again depending on how they do it. Diet and exercise tend to get cultural approval. Medication-assisted weight loss often does not.

This creates a strange and unfair bind.

If someone does not lose weight, they may be criticized for “not taking care of themselves.” If they lose weight with the help of medication, they may be accused of taking a shortcut. If they stop the medication and regain weight, they may be blamed for failing.

That is a lot of judgment to place on a person’s body, health history, medical decisions, and life circumstances.

A 2026 study published in the International Journal of Obesity looked directly at this issue. Researchers wanted to understand how people judge those who lose weight using GLP-1 medications, and how they judge people who regain weight after stopping them.

The results are uncomfortable, but useful.

They show how easily weight loss gets turned into a moral story. They also remind us that health decisions are rarely as simple as outside observers want them to be.

GLP-1 medications are not magic. They are not effortless. They are not right for everyone. But using them should not make someone a target for shame.

And regaining weight after stopping them should not be treated as proof that someone failed.

What the Science Says

The study was conducted by Erin C. Standen, Sean M. Phelan, and A. Janet Tomiyama.

The authors described the purpose clearly: GLP-1 medications can be effective for weight loss, but when people discontinue them, weight regain is common. The researchers wanted to examine the stigma of losing and regaining weight after GLP-1 use and cessation.

As the authors put it, “people may face stigma across the cycle” of weight loss and regain after using a GLP-1.

The researchers conducted two online experiments with U.S. adults recruited through a survey platform.

Study 1: How are people judged when they lose weight with a GLP-1?

In Study 1, 607 participants read a brief profile of a fictional 38-year-old person who had lived with obesity since puberty and weighed around 220 pounds.

Participants were randomly assigned to one of three versions of the story:

1. The person lost 35 pounds over the past year using a GLP-1.

2. The person lost 35 pounds by changing their diet and exercising regularly.

3. The person had not attempted weight loss.

   
   

Both weight-loss stories specified that the person was no longer in the “obese” BMI category.

After reading the profile, participants rated the fictional person on several outcomes:

• Positive traits, on a 1 to 7 scale

• Negative traits, on a 1 to 7 scale

• Perceived unhealthiness, on a 1 to 7 scale

• Willingness to affiliate, on a 1 to 7 scale

• Perceived socioeconomic status

  
  

Participants also completed assessments measuring explicit weight bias and internalized weight bias. Explicit weight bias included things like empathy toward higher-weight people and beliefs about whether weight is mostly a matter of personal responsibility and willpower. Internalized weight bias measured the degree to which participants applied negative societal beliefs about higher-weight bodies to themselves.

The researchers expected that the person who had not attempted weight loss would probably face the harshest judgment.

That is not what happened.

Here is what they found:

Rating	Lost weight via GLP-1	Lost weight via diet and exercise	Did not attempt weight loss
Positive traits score	4.59	4.93	4.88
Negative traits score	2.63	2.18	2.45
Perceived unhealthiness	3.21	2.59	3.45
Willingness to affiliate	4.99	5.51	5.25

Participants rated the person who lost weight with a GLP-1 less favorably across the board.

They viewed the GLP-1 user as having fewer positive traits, more negative traits, being less healthy, and being someone they were less willing to affiliate with.

One of the most striking findings was that the GLP-1 user was rated more poorly than someone who still had obesity and had not attempted weight loss at all.

That tells us something important.

The judgment was not only about body size. It was also about the method of weight loss.

The person who lost weight through diet and exercise was viewed most favorably. The person who used a GLP-1 was socially penalized. This fits with the common narrative that medication-assisted weight loss is “taking the easy way out,” a phrase the researchers discussed in the paper as part of the stigma surrounding GLP-1 use.

Not surprisingly, people with stronger “responsibility” beliefs about weight judged the GLP-1 user especially harshly. In other words, participants who were more likely to believe that weight is fully within a person’s control were less willing to affiliate with someone who lost weight using medication.

Low empathy toward higher-weight people also predicted harsher judgment.

Study 2: How are people judged when they regain weight?

In Study 2, 706 participants read one of four versions of a fictional person’s story:

1. The person regained weight after stopping a GLP-1.

2. The person regained weight after stopping a diet and exercise program.

3. The person never attempted weight loss.

4. The person lost weight and kept it off, though the method was unspecified.

Again, participants rated the fictional person on positive traits, negative traits, perceived unhealthiness, willingness to affiliate, and perceived socioeconomic status.

The researchers expected that the person who regained weight after stopping a GLP-1 might be judged most harshly. The idea was that people might think, “You had access to this powerful medication and still regained the weight.”

But the results were a little different.

Here is what they found:

Rating	Regained after GLP-1	Regained after diet and exercise	Did not attempt weight loss	Maintained weight loss
Positive traits score	4.56	4.66	4.85	4.80
Negative traits score	3.15	3.16	2.82	2.35
Perceived unhealthiness	4.17	3.94	3.81	2.83
Willingness to affiliate	5.02	5.11	5.24	5.33

In this study, weight regain itself seemed to trigger the harshest judgment.

The person who regained weight after stopping a GLP-1 and the person who regained weight after stopping diet and exercise were viewed similarly. The method of weight loss mattered less once regain happened.

Meanwhile, the person who lost weight and maintained it was rated more favorably than all other groups across the board.

That is not shocking, but it is revealing. We tend to praise the outcome we like and judge the outcome we dislike, often without knowing much about the person’s biology, environment, medical history, stress, finances, or support system.

In both Study 1 and Study 2, knowing someone used a GLP-1 did not lead participants to assume their socioeconomic status was higher or lower.

What the findings suggest

This study suggests that people may be judged for using GLP-1s to lose weight, and they may also be judged if they regain weight after stopping.

The first part is especially important. Many people assume that losing weight reduces weight stigma. But in this study, losing weight with a GLP-1 did not protect the fictional person from stigma. In some ways, it seemed to create a different kind of stigma.

The second part matters too. Weight regain was judged harshly regardless of whether the original weight loss came from medication or diet and exercise.

So the stigma follows people in multiple directions.

At a higher weight, they may be judged for their body size.

If they lose weight with medication, they may be judged for the method.

If they regain weight, they may be judged for the outcome.

That is the “damned if you do, damned if you don’t” problem.

What the study does not prove

This study does not prove that everyone will judge GLP-1 users this way in real life.

The participants were reading short fictional profiles. Real people are more complicated than a paragraph on a screen. In real life, we may know someone’s medical history, years of previous weight-loss attempts, family situation, training habits, health markers, or reasons for choosing a medication.

We also usually do not know how someone lost or regained weight unless they tell us.

That matters.

It is much easier to judge a one-dimensional fictional person than a real human being with a full life.

The study also does not tell us whether someone should or should not use a GLP-1. That is a medical decision to make with a qualified healthcare provider.

What the study does show is that bias around body weight, effort, medication, and regain is real enough to measure.

And that should make all of us pause.

What This Means in Real Life

The practical takeaway is not that GLP-1s are good or bad.

The better takeaway is that people deserve less judgment and better support around weight, health, and weight-loss decisions.

GLP-1 medications can be powerful tools. They can reduce appetite, quiet food noise, improve blood sugar control for many people, and help produce clinically meaningful weight loss. They can also come with side effects, cost barriers, insurance issues, long-term uncertainty, and difficult decisions about whether to continue or stop.

That is not a simple situation.

And it definitely is not a moral shortcut.

Using a medication does not remove the need for behavior change. Someone using a GLP-1 still has to navigate protein intake, resistance training, hydration, fiber, meal timing, digestion, social eating, body composition, and long-term maintenance.

In some ways, those habits become even more important.

When appetite is lower, it can be harder to eat enough high-quality nutrition. If someone is losing weight quickly, preserving muscle matters. Strength training and adequate protein are not side notes. They are central parts of protecting health during weight loss.

This is where the conversation needs more maturity.

A person using a GLP-1 is not automatically lazy.

A person losing weight through diet and exercise is not automatically morally superior.

A person regaining weight is not automatically careless.

And a person maintaining weight loss is not automatically more disciplined or virtuous than everyone else.

Body weight is influenced by behavior, yes. But it is also influenced by appetite regulation, genetics, medications, sleep, stress, environment, finances, injury history, mental health, hormones, food access, social support, and time.

Personal responsibility matters. But pretending weight is only about willpower is not honest.

That belief may feel satisfying to people who want a simple explanation, but it does not match the reality most people live with.

The study also gives us a useful reminder about regain.

When people stop GLP-1 medications, weight regain is common. That does not mean they failed. These medications affect appetite and energy regulation. When the medication is removed, those biological pressures can return.

The same broader principle applies to diet-and-exercise weight loss. Maintaining weight loss is often harder than losing it because the body adapts. Hunger can increase. Energy expenditure can decrease. Old patterns can return. Stress can disrupt routines. Life can get busy. Support can fade.

That does not mean people are powerless.

It means the maintenance plan needs to be realistic.

Weight loss should never be treated as a temporary project where someone white-knuckles their way to a lower number and then hopes everything stays fixed. Whether someone uses medication or not, long-term success requires repeatable habits, flexible structure, and a plan that fits the person’s actual life.

Practical Takeaways

1. If you are considering a GLP-1, make it a medical decision, not a shame decision

The right question is not, “Is this cheating?”

A better set of questions would be:

• Is this appropriate for my health situation?

• Have I talked through the risks and benefits with my doctor?

• Do I understand the side effects?

• Can I access and afford the medication consistently?

• What happens if I need or choose to stop?

• How will I support muscle, nutrition, and long-term maintenance?

Those are adult questions.

“Am I taking the easy way out?” is usually shame dressed up as self-reflection.

2. Do not let other people turn your health into a purity contest

People have opinions. Many of them are loud. Many of them are poorly informed.

You do not owe everyone an explanation for your medical choices.

If someone asks a question that feels intrusive, you can keep it simple:

“My doctor and I decided this was the right approach for my health.”

That can be the whole sentence.

You are allowed to have privacy. You are allowed to make medical decisions without turning your body into a group project.

3. Keep strength training and protein in the picture

If weight loss is the goal, the goal should not simply be to weigh less.

The goal should be to lose weight while protecting as much strength, muscle, function, and health as possible.

That usually means resistance training, enough protein, enough overall nutrition, and a plan for recovery.

This matters whether weight loss comes from a GLP-1, nutrition changes, increased exercise, or a combination.

The scale is one piece of feedback. It is not the whole story.

4. If weight regain happens, respond with curiosity instead of self-attack

Regain is not a personal defect.

It is information.

Useful questions include:

• Did hunger change?

• Did medication stop or change?

• Did protein intake drop?

• Did strength training become inconsistent?

• Did stress increase?

• Did sleep get worse?

• Did the original plan require too much restriction?

• Was there a maintenance plan, or only a weight-loss plan?

• What support would make the next phase more sustainable?

These questions lead somewhere useful.

Shame usually leads to hiding, quitting, or swinging into another extreme plan.

5. Watch for your own bias

This study is about social judgment, which means it is about all of us.

It is worth asking:

Do I respect weight loss more when someone does it through diet and exercise alone?

Do I assume medication means someone avoided doing the work?

Do I believe results only “count” if they involved enough struggle?

Do I judge people more harshly when they regain weight?

These beliefs are common because our culture tends to glorify willpower and visible effort. But common beliefs are not always fair or accurate.

Medication can be a tool.

Nutrition structure can be a tool.

Macro tracking can be a tool.

Strength training can be a tool.

Therapy can be a tool.

Surgery can be a tool.

Support is not cheating. Tools are not moral failures.

6. Think about maintenance from the beginning

Maintenance is not something to figure out later.

It needs to be part of the plan early.

That means practicing habits that can survive real life: busy weeks, restaurants, travel, stress, holidays, boredom, injury, schedule changes, and imperfect motivation.

A good maintenance plan may include:

• Regular strength training

• Consistent protein intake

• Enough fiber and fluids

• Reasonable food tracking or portion awareness

• Sleep routines

• Weight or habit monitoring without obsession

• Flexible meal planning

• A plan for social eating

• Medical follow-up when needed

• Honest conversations about what feels sustainable

The goal is not to create a perfect routine.

The goal is to create enough structure that you can keep coming back to it.

Closing Thoughts From Two Decades of Coaching

After two decades in coaching, I have seen how much pain people carry around body weight.

They carry old comments.

They carry failed diet attempts.

They carry doctor’s office shame.

They carry family expectations.

They carry comparison.

They carry the feeling that their body is always being evaluated, even when nobody says anything out loud.

That is why this study matters.

It gives data to something many people already feel. The rules around weight are often unfair and contradictory.

People at a higher weight are judged. People who use medication to lose weight are judged. People who regain weight are judged. People who maintain weight loss are praised, often without anyone knowing what it took, what it cost, or what support they had.

This is not a healthy way to think about health.

A better approach starts with seeing people as people.

Not as a before picture.

Not as an after picture.

Not as a medication user.

Not as a regain story.

Not as a willpower score.

Just a person trying to live in a body, manage their health, and make decisions with the tools available to them.

That does not mean every tool is right for every person.

GLP-1s are not for everyone.

Dieting is not appropriate for everyone.

Tracking may help one person and overwhelm another. Some people need medical intervention. Some need more structure. Some need more flexibility. Some need to stop chasing weight loss for a while and rebuild trust with their body.

Context matters.

But contempt does not help.

Judgment does not make people healthier. Shame does not preserve muscle, improve blood sugar, build habits, strengthen relationships, or teach someone how to maintain progress.

Support does.

Clear information does.

Consistent habits do.

Strength training does.

Protein helps.

Sleep helps.

Medical care can help.

Honest reflection helps.

And compassion gives people enough breathing room to keep going.

The point of health is not to prove you suffered enough to deserve it.

The point is to build a life that feels better, works better, and gives you more freedom to do what matters.

That is true whether your path includes a GLP-1 or not. - Michael Beiter Certified Personal Trainer Nutrition, Sleep, Stress Management and Recovery Coach

References

Standen EC, Phelan SM, Tomiyama AJ. “An experimental investigation of the stigmatization of weight loss and regain from GLP-1 receptor agonist use and cessation.” International Journal of Obesity. 2026. https://doi.org/10.1038/s41366-026-02061-y

Tomiyama AJ, Carr D, Granberg EM, Major B, Robinson E, Sutin AR, et al. “How and why weight stigma drives the obesity ‘epidemic’ and harms health.” BMC Medicine. 2018;16:123.

Vartanian LR, Fardouly J. “The stigma of obesity surgery: negative evaluations based on weight loss history.” Obesity Surgery. 2013;23:1545–50.

Post SM, Persky S. “The effect of GLP-1 receptor agonist use on negative evaluations of women with higher and lower body weight.” International Journal of Obesity. 2024;48:1019–26.

Rubino D, Abrahamsson N, Davies M, et al. “Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial.” JAMA. 2021;325:1414–25.

Aronne LJ, Sattar N, Horn DB, et al. “Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial.” JAMA. 2024;331:38–48.

Phelan SM, Bauer KW, Bradley D, et al. “A model of weight-based stigma in health care and utilization outcomes: Evidence from the learning health systems network.” Obesity Science & Practice. 2021;8:139–46.